Analyst Expectations for Eli Lilly's Future
Portfolio Pulse from Benzinga Insights
Eli Lilly (NYSE:LLY) has received predominantly bullish ratings from analysts in the last quarter, with 3 bullish, 11 somewhat bullish, and 1 indifferent rating. The average 12-month price target for LLY is $642.33, which is an 8.29% increase from the previous target of $593.14. The high estimate is $722.00 and the low is $535.00. Analysts' ratings are based on financial predictions and company performance, and are updated quarterly or after major company events.
November 20, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly has received a strong vote of confidence from analysts with the majority issuing bullish or somewhat bullish ratings. The average price target has been raised to $642.33, indicating a positive outlook for the stock.
The positive analyst ratings and the increased average price target suggest that the market's outlook on Eli Lilly is optimistic. This could lead to a short-term increase in the stock price as investors react to the favorable analysis. The confidence score is high due to the clear consensus among analysts and the significant increase in the price target.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100